https://www.selleckchem.com/products/zeocin.html
During the follow-up period, 93/122 patients (70.1%) died from the disease, with a median survival time of 10.5 months (range 1 to 104 mo). Kaplan-Meier analyses demonstrated that the prognosis was better for adult patients than the pediatric cohort (P=0.0003). Multivariate analyses indicated that patient age, primary tumor size, status of ATRX expression, and Ki-67 index were independent prognosticators. The present study showed that there were differences between adult and pediatric H3 K27M-mt DMGs in terms of the anatomic location of
Like
Comment
Share
